Wellfount Corporation Closes $6M Series A Funding Round

Wellfount Corporation, an institutional pharmacy that provides pharmaceutical products and services to both local and national long-term care facilities, has closed a $6m Series A funding round with Arboretum Ventures.

The company intends to use the funds to continue to expand its services nationwide  and roll-out its innovative pharmacy distribution and dispensing technologies.

Founded in 2006 by CEO Paul Leamon, Wellfount provides drug regimen reviews, packaging, distribution and charting solutions to patients that reside in long-term care facilities such as nursing homes.

Its technologies are designed to cut the number of individual touches of a drug order from physician to patient, provide just-in-time dispense at the point of patient care, and integrate the nurses documentation into the patient record.



Join the discussion